Stelara Indications/Uses

Plaque Psoriasis: Adults: Ustekinumab (Stelara) is indicated for: Treatment of psoriasis; Improving health related quality of life in adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Psoriatic Arthritis (PsA): Ustekinumab (Stelara), alone or in combination with methotrexate (MTX), is indicated for: Reducing signs and symptoms; Improving physical function; Inhibiting the progression of structural damage; Improving enthesitis; Improving psoriasis; Improving health-related quality of life in adults with active psoriatic arthritis.
Crohn's Disease: Ustekinumab (Stelara) is indicated for: Inducing and maintaining clinical response; Inducing and maintaining clinical remission; Eliminating corticosteroid use; Inducing endoscopic healing; Improving health-related quality of life.
In adults with moderately to severely active Crohn's disease who: Have failed or were intolerant to immunomodulators or corticosteroids or were corticosteroid dependent or have failed or were intolerant to one or more anti-TNF treatment.
Ulcerative Colitis: Ustekinumab (Stelara) is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.